Miguel Angel
Canales Albendea
Consultor Médico
![Foto de Miguel Angel](/img/nophoto.png)
![Foto de French Institute of Health and Medical Research](/img/noimage_org.png)
French Institute of Health and Medical Research
París, FranciaFrench Institute of Health and Medical Research-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2022
-
Effect of Prior Therapy and Disease Refractoriness on the Efficacy and Safety of Oral Selinexor in Patients with Diffuse Large B-cell Lymphoma (DLBCL): A Post-hoc Analysis of the SADAL Study
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, Núm. 7, pp. 483-494